「Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies」の関連論文
-
Efficacy and Safety of Adalimumab Therapy for the Treatment of Non-infectious Uveitis: Efficacy comparison among Uveitis Aetiologies
-
Rituximab in combination with cyclosporine and steroid pulse therapy for childhood-onset multidrug-resistant nephrotic syndrome: a multicenter single-arm clinical trial (JSKDC11 trial)
-
Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases
-
Factors associated with the response to atezolizumab/bevacizumab combination therapy for hepatocellular carcinoma
-
Outcomes of the Sequential Treatment of Unresectable Hepatocellular Carcinoma Using Lenvatinib
-
Short-Term Outcomes of Intravitreal Faricimab Injection for Diabetic Macular Edema
-
Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer
-
Safety and tolerability of bosutinib in patients with amyotrophic lateral sclerosis (iDReAM study): A multicentre, open-label, dose-escalation phase 1 trial
-
Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.
-
A case of chronic eosinophilic pneumonia associated with rheumatoid arthritis in glucocorticoid-free remission with JAK inhibitor: A case report
-
Impact of thoracic esophageal displacement after lobectomy on the continuity of oral adjuvant chemotherapy.
-
Statin Use Influence on the Occurrence of Acute Kidney Injury in Patients with Peripheral Arterial Disease
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
Docetaxel plus cisplatin in recurrent and/or metastatic non-squamous-cell head and neck cancer: a multicenter phase II trial
-
Oral Valganciclovir Therapy in Infants Aged ≤2 Months with Congenital Cytomegalovirus Disease: A Multicenter, Single-Arm, Open-Label Clinical Trial in Japan
-
Edoxaban for 12 Months Versus 3 Months in Cancer Patients With Isolated Distal Deep Vein Thrombosis (ONCO DVT study): An Open-label, Multicenter, Randomized Clinical Trial
-
Favorable effect of ripasudil use on surgical outcomes of microhook ab interno trabeculotomy
-
転移性尿路上皮癌に対するGC療法における, Gemcitabine投与後の発熱の臨床的意義の検討: 多施設共同後ろ向き研究
-
A case of systemic lupus erythematosus/systemic sclerosis overlap syndrome successfully treated with belimumab
-
Number of concomitant drugs with thrombocytopenic adverse effects and the extent inflammatory response resolution are risk factors for thrombocytopenia in patients treated with linezolid for more than 14 days
-
Effectiveness of Profiling Serum IL-18 and Neopterin in Diagnosis of Adult-Onset Still's Disease Complicated by Pulmonary Tuberculosis: A Case Report
-
TAPO in first-line osimertinib therapy and continuation of osimertinib
-
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors
-
Factors causing a relapse of major depressive disorders following successful electroconvulsive therapy : A retrospective cohort study
-
Effectiveness of tolvaptan and long-term prognosis in patients with liver cirrhosis
-
光力学診断補助下経尿道的膀胱腫瘍切除術(PDD-TURBT)の初期経験
-
Opioid therapy duration before naldemedine treatment is a significant independent risk of diarrhea: a retrospective cohort study
-
Utility of plasma circulating tumor DNA and tumor DNA profiles in head and neck squamous cell carcinoma
-
Autoantibodies against the plakin family proteins as a novel marker for chronic graft-versus-host disease of the lung
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
-
Kynurenic acid is a potential overlapped biomarker between diagnosis and treatment response for depression from metabolome analysis
-
Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
-
分子標的薬時代における転移性腎癌の腫瘍縮小率が予後に与える影響
-
Combined Hypophysitis and Type 1 Diabetes Mellitus Related to Immune Checkpoint Inhibitors
-
Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer
-
Influence of the Preoperative Duration of Symptoms on Patients' Clinical Outcomes after Minimally Invasive Surgery-Transforaminal Lumbar Interbody Fusion for Degenerative Lumbar Spinal Diseases
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
Local radiotherapy for pleural dissemination of thymic tumors after initial treatment
-
Clinical Significance of Serum Galectin-9 and Soluble CD155 Levels in Patients with Systemic Sclerosis
-
Relative hypercoagulation induced by suppressed fibrinolysis after tisagenlecleucel infusion in malignant lymphoma
-
Targeted temperature management guided by the severity of hyperlactatemia for out-of-hospital cardiac arrest patients : a post hoc analysis of a nationwide, multicenter prospective registry
-
泌尿器癌患者における骨吸収抑制剤関連顎骨壊死の発生頻度の検討
-
Asymptomatic Idiopathic Renal Infarction Detected Incidentally on Contrast-Enhanced Computed Tomography: A Case Report
-
Congenital Isolated Unilateral Agenesis of Pulmonary Arteries with 3-Year Follow-Up after Initiation of Treatment
-
Clinicopathologic factors associated with tumor necrosis after preoperative embolization of meningiomas
-
Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
Effectiveness and safety of lower dose sulfamethoxazole/trimethoprim therapy for Pneumocystis jirovecii pneumonia in patients with systemic rheumatic diseases : A retrospective multicenter study
-
Apixaban in Japanese patients with cancer-associated venous thromboembolism: a multi-center phase II trial
-
Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer